94. Hegi, M.E., et al., MGMT gene silencing and benefit from temozolomide in glioblastoma. New England Journal of Medicine, 2005. 352: p. 997- 1003, 2005 Mar 10. I-ATTAC Version: 20220204 61 95. Stupp, R., et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. New England Journal of Medicine., 2005. 352(10): p. 987 -996. 96. Walker, R.E., et al., Long -term in vivo survival of recepto r-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood, 2000. 96(2): p. 467 -74.